Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,030 | -3,905 | -16,461 | -12,303 | -8,533 |
| Depreciation Amortization | 249 | 127 | 860 | 702 | 484 |
| Accounts receivable | 46 | 52 | 19 | 58 | 63 |
| Other Working Capital | 332 | 138 | 253 | 588 | 693 |
| Other Operating Activity | 600 | 228 | 2,130 | 1,369 | 1,187 |
| Operating Cash Flow | $-6,803 | $-3,360 | $-13,199 | $-9,586 | $-6,107 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 0 | 0 | -32 |
| PPE Investments | -5 | -5 | 23 | 23 | -5 |
| Investing Cash Flow | $-5 | $-5 | $23 | $23 | $-37 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,187 | 3,282 | 13,392 | 13,392 | 13,392 |
| Other Financing Activity | -40 | -40 | 3,011 | 3,011 | 3,011 |
| Financing Cash Flow | $6,147 | $3,242 | $16,404 | $16,404 | $16,404 |
| Beginning Cash Position | 11,453 | 11,453 | 8,226 | 8,226 | 8,226 |
| End Cash Position | 10,791 | 11,330 | 11,453 | 15,066 | 18,486 |
| Net Cash Flow | $-662 | $-123 | $3,227 | $6,840 | $10,260 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,803 | -3,360 | -13,199 | -9,586 | -6,107 |
| Capital Expenditure | -5 | -5 | -5 | -5 | -5 |
| Free Cash Flow | -6,809 | -3,365 | -13,204 | -9,591 | -6,112 |